Are the effects of α-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract?

FEBS Letters

Volumn 583, Issue 13, 2009, Pages 2157-2159

  Suzuki, Yoshihiko ^a   Sano, Motoaki ^b   Hayashida, Kentaro ^b   Ohsawa, Ikuroh ^a   Ohta, Shigeo ^a   Fukuda, Keiichi ^b  

^a Graduate School of Medicine   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glucosidase inhibitors; Antioxidant; Hydrogen gas; Type 2 diabetes

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; HYDROGEN; LIPOXYGENASE; METHANE; NITRIC OXIDE; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; XANTHINE OXIDASE;

ANGINA PECTORIS; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DRUG TARGETING; DRUG TRANSPORT; FLATULENCE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIMARY PREVENTION; PRIORITY JOURNAL;

ACARBOSE; ALPHA-GLUCOSIDASES; ANTIOXIDANTS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; ENZYME INHIBITORS; FEMALE; FLATULENCE; GASTROINTESTINAL TRACT; HUMANS; HYDROGEN; MALE; MYOCARDIUM;

EID: 67649321238     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.05.052     Document Type: Article

References (19)

1. Coutinho M., Gerstein H.C., Wang Y., and Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22 (1999) 233-240
2. Barrett-Connor E., and Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The rancho bernardo study. Diabetes Care 21 (1998) 1236-1239
3. Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., and Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290 (2003) 486-494
4. Hanefeld M., Cagatay M., Petrowitsch T., Neuser D., Petzinna D., and Rupp M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur. Heart J. 25 (2004) 10-16
5. (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352, 837-853.
6. Frantz S., Calvillo L., Tillmanns J., Elbing I., Dienesch C., Bischoff H., Ertl G., and Bauersachs J. Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury: prevention by the α-glucosidase inhibitor acarbose. FASEB J. 19 (2005) 591-593
7. Madamanchi N.R., Hakim Z.S., and Runge M.S. Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes. J. Thromb. Haemost. 3 (2005) 254-267
8. Touyz R.M. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?. Hypertension 44 (2004) 248-252
9. Wilcox C.S. Redox regulation of the afferent arteriole and tubuloglomerular feedback. Acta Physiol. Scand. 179 (2003) 217-223
10. Steinhubl S.R. Why have antioxidants failed in clinical trials?. Am. J. Cardiol. 101 (2008) 14D-19D
11. Ohsawa I., et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat. Med. 13 (2007) 688-694
12. Hayashida K., et al. Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem. Biophys. Res. Commun. 373 (2008) 30-35
13. Kajiyama S., et al. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr. Res. 28 (2008) 137-143
14. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241
15. Berliner J.A., and Watson A.D. A role for oxidized phospholipids in atherosclerosis. N Engl. J. Med. 353 (2005) 9-11
16. Ohsawa I., Nishimaki K., Yamagata K., Ishikawa M., and Ohta S. Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice. Biochem. Biophys. Res. Commun. 377 (2008) 1195-1198
17. Adams M.W., Mortenson L.E., and Chen J.S. Hydrogenase. Biochim. Biophys. Acta 594 (1980) 105-176
18. Levitt M.D. Production and excretion of hydrogen gas in man. N Engl. J. Med. 281 (1969) 122-127
19. Ladas S.D., Frydas A., Papadopoulos A., and Raptis S.A. Effects of α-glucosidase inhibitors on mouth to caecum transit time in humans. Gut 33 (1992) 1246-1248